ALBIREO PHARMA, INC. Quarterly Common Stock, Shares, Issued from Q3 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Albireo Pharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q3 2022.
  • Albireo Pharma, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2022 was 20.7M shares, a 7.35% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 20.7M +1.42M +7.35% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 19.6M +370K +1.92% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 19.5M +335K +1.75% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 19.3M +197K +1.03% Dec 31, 2021 10-Q 2022-11-08
Q3 2021 19.3M +210K +1.1% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 19.2M +4.25M +28.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 19.2M +4.21M +28.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 19.1M +6.36M +49.9% Dec 31, 2020 10-K 2022-03-01
Q3 2020 19.1M +6.39M +50.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 15M +2.3M +18.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 15M +2.94M +24.4% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 12.7M +780K +6.51% Dec 31, 2019 10-K 2021-02-25
Q3 2019 12.7M +715K +5.98% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 12.7M +728K +6.09% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 12M +142K +1.19% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 12M +3.07M +34.5% Dec 31, 2018 10-Q 2019-11-06
Q3 2018 12M +3.09M +34.8% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 12M +3.1M +35% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 11.9M +5.6M +89.1% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 8.9M +2.61M +41.5% Dec 31, 2017 10-K 2019-03-06
Q3 2017 8.88M +6.74M +315% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 8.86M -55.3M -86.2% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 6.29M -57.9M -90.2% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 6.29M +6.29M Dec 31, 2016 10-K 2018-03-27
Q3 2016 2.14M +66.6K +3.21% Sep 30, 2016 10-K 2016-12-22
Q2 2016 64.1M +2M +3.21% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 64.1M +39.5M +161% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 0 -23.5M -100% Dec 31, 2015 10-K 2017-03-27
Q3 2015 2.07M -21M -91% Sep 30, 2015 10-K 2016-12-22
Q2 2015 62.2M +41M +194% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 24.6M +3.5M +16.6% Mar 31, 2015 10-Q/A 2015-06-01
Q4 2014 23.5M +2.38M +11.3% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 23.1M +2.01M +9.53% Sep 30, 2014 10-K 2015-12-22
Q2 2014 21.1M +2.22M +11.7% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 21.1M +6.91M +48.7% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 21.1M +6.9M +48.7% Dec 31, 2013 10-Q 2014-02-10
Q3 2013 21.1M +6.9M +48.7% Sep 30, 2013 10-K 2014-12-19
Q2 2013 18.9M +14.7M +345% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 14.2M -24.7M -63.5% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 14.2M -24.5M -63.4% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 14.2M +4.51M +46.7% Sep 30, 2012 10-K 2013-12-20
Q2 2012 4.25M -34.4M -89% Jun 30, 2012 10-K 2012-12-21
Q1 2012 38.9M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 38.7M Dec 31, 2011 10-Q 2012-02-09
Q3 2011 9.66M -16.7M -63.4% Sep 30, 2011 10-K 2012-12-21
Q2 2011 38.6M Jun 30, 2011 10-Q 2011-08-09
Q3 2010 26.4M Sep 30, 2010 10-K 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.